Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia ; volume:37 ; number:7 ; day:20 ; month:7 ; year:2023 ; pages:545-570 ; date:7.2023
CNS drugs ; 37, Heft 7 (20.7.2023), 545-570, 7.2023
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40263-023-01022-7
- URN
-
urn:nbn:de:101:1-2023103013015793010989
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Meyer, Jonathan M.
- Correll, Christoph U.
- SpringerLink (Online service)
Other Objects (12)
Targeting metabotropic glutamate receptors for novel treatments of schizophrenia
Clinical Efficacy and Safety of Psoriasis Treatments in Patients with Concomitant Metabolic Syndrome: A Narrative Review
Risk Analysis of Prostate Cancer Treatments in Promoting Metabolic Syndrome Development and the Influence of Increased Metabolic Syndrome on Prostate Cancer Therapeutic Outcome
Metabolic changes in schizophrenia and human brain evolution
Brain metabolism revisited - concepts and treatments : metabolic epileptic encephalopathies
The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis
Differences in schizophrenia treatments by race and ethnicity—analysis of electronic health records
Reduced mismatch negativity and increased variability of brain activity in schizophrenia
Transcriptome analysis in whole blood reveals increased microbial diversity in schizophrenia
Prevalence of metabolic syndrome among patients with Schizophrenia in Palestine
Prevalence of metabolic syndrome among patients with schizophrenia in Ethiopia
An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia
Targeting metabotropic glutamate receptors for novel treatments of schizophrenia
Clinical Efficacy and Safety of Psoriasis Treatments in Patients with Concomitant Metabolic Syndrome: A Narrative Review
Risk Analysis of Prostate Cancer Treatments in Promoting Metabolic Syndrome Development and the Influence of Increased Metabolic Syndrome on Prostate Cancer Therapeutic Outcome
Metabolic changes in schizophrenia and human brain evolution
Brain metabolism revisited - concepts and treatments : metabolic epileptic encephalopathies
The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis
Differences in schizophrenia treatments by race and ethnicity—analysis of electronic health records
Reduced mismatch negativity and increased variability of brain activity in schizophrenia
Transcriptome analysis in whole blood reveals increased microbial diversity in schizophrenia
Prevalence of metabolic syndrome among patients with Schizophrenia in Palestine
Prevalence of metabolic syndrome among patients with schizophrenia in Ethiopia
An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia
Targeting metabotropic glutamate receptors for novel treatments of schizophrenia
Clinical Efficacy and Safety of Psoriasis Treatments in Patients with Concomitant Metabolic Syndrome: A Narrative Review
Risk Analysis of Prostate Cancer Treatments in Promoting Metabolic Syndrome Development and the Influence of Increased Metabolic Syndrome on Prostate Cancer Therapeutic Outcome
Metabolic changes in schizophrenia and human brain evolution
Brain metabolism revisited - concepts and treatments : metabolic epileptic encephalopathies
The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis
Differences in schizophrenia treatments by race and ethnicity—analysis of electronic health records
Reduced mismatch negativity and increased variability of brain activity in schizophrenia
Transcriptome analysis in whole blood reveals increased microbial diversity in schizophrenia
Prevalence of metabolic syndrome among patients with Schizophrenia in Palestine
Prevalence of metabolic syndrome among patients with schizophrenia in Ethiopia